Role of DNA mismatch repair in apoptotic responses to therapeutic agents
β Scribed by Mark Meyers; Arlene Hwang; Mark W. Wagner; David A. Boothman
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 162 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0893-6692
- DOI
- 10.1002/em.20056
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Together with tolerance to killing induced by methylating agents, loss of mismatch repair (MMR) has previously been found to be associated with hypersensitivity to the DNAcross-linking agent 1-(2-chloroethyl)-3-cyclohexyl-nitrosourea(CCNU) in several human tumor cell lines (Aquilina et al., 1998). H
Staurosporine induced apoptosis in a human oligodendroglioma cell line (HOG), neonatal rat oligodendrocyte (O2A Ψ ) precursors, and mature rat oligodendrocytes. In all three cell culture systems, the activation of caspase-3-like activity (CPP32) coincided with the increased formation of ceramide fro
Hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome is caused by DNA variations in the DNA mismatch repair (MMR) genes MSH2, MLH1, MSH6, and PMS2. Many of the mutations identified result in premature termination of translation and thus in loss-of-function of the encoded mutated prote
Cell killing by monofunctional methylating agents is due mainly to the formation of adducts at the O 6 position of guanine. These methyl adducts are removed from DNA by the O 6 -alkylguanine DNA alkyltransferase (OGAT). The mechanism by which O 6 -methylguanine (O 6 meG) induces cell death in OGAT-d